ACLIPSE THERAPEUTICS

Aclipse Therapeutics develops novel and highly differentiated therapeutics to treat life-threatening and severe diseases. Our approach leverages the wealth of human genomic, proteomic and biomarker data to develop disease-modifying drug candidates... Aclipse Therapeutics focuses on molecular pathways that regulate cellular stress, protein misfolding and inflammation. Our focus is on neurodegenerative and gastrointestinal diseases that are strongly impacted by these molecular pathways. We believe that developing precision medicine approaches will allow for the identification of potential drug responders and thereby improve patient outcomes... Aclipse management team has extensive experience in pharmaceutical research, regulatory and clinical development, manufacturing, and drug product introductions. In addition, our team has a strong proven track record in business development, including in- and out-licensing, acquisitions, and collaborations. Aclipse management team recently exited..